• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲实验中,传播阻断活性由传播减少活性和对照卵囊数量共同决定。
Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.
2
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data.利用经验数据评估标准膜饲血试验(SMFA)在测定疟疾传播减少活性方面的应用。
Parasitology. 2005 Jan;130(Pt 1):13-22. doi: 10.1017/s0031182004006067.
3
Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲检测中,卵囊和子孢子强度的抑制率之间具有高度一致性。
Parasit Vectors. 2019 May 6;12(1):206. doi: 10.1186/s13071-019-3470-3.
4
Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines.评价和建立恶性疟原虫直接膜 feeding 检测方法以支持传播阻断疫苗的研发。
Sci Rep. 2020 Jul 28;10(1):12569. doi: 10.1038/s41598-020-69513-x.
5
Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.比较评估冈比亚按蚊和斯蒂芬斯按蚊,以确定针对疟原虫有性阶段抗原的抗体的传播减少活性。
Parasit Vectors. 2017 Oct 17;10(1):489. doi: 10.1186/s13071-017-2414-z.
6
An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.用于评估疟疾传播阻断疫苗的标准膜饲法的实验室间比较。
Malar J. 2016 Sep 9;15(1):463. doi: 10.1186/s12936-016-1515-z.
7
Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays.标准膜饲法检测恶性疟原虫疟疾的资质和未来检测方法的潜在改进。
PLoS One. 2013;8(3):e57909. doi: 10.1371/journal.pone.0057909. Epub 2013 Mar 6.
8
A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase.在标准膜饲法中,使用表达绿色荧光蛋白 - 荧光素酶的转基因疟原虫对恶性疟原虫传播进行可扩展评估。
J Infect Dis. 2014 Nov 1;210(9):1456-63. doi: 10.1093/infdis/jiu271. Epub 2014 May 14.
9
Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.用于评估疫苗和药物对恶性疟原虫传播阻断活性的稳健、可重复、工业化标准膜饲法。
Malar J. 2015 Apr 9;14:150. doi: 10.1186/s12936-015-0665-8.
10
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.疟疾候选疫苗Pfs25/Pvs25诱导的传播阻断活性是抗体滴度的直接且可预测的函数。
Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107.

引用本文的文献

1
Magnitude and durability of ProC6C-AlOH/Matrix-M vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trial.1期随机试验中,ProC6C-AlOH/Matrix-M疫苗在布基纳法索成年人中诱导产生的疟疾传播阻断抗体的强度和持久性
Hum Vaccin Immunother. 2025 Dec;21(1):2488075. doi: 10.1080/21645515.2025.2488075. Epub 2025 Apr 10.
2
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa.间日疟原虫重组蛋白rPvs48/45与非洲恶性疟原虫流行地区血浆的交叉反应性。
PLoS One. 2025 Mar 18;20(3):e0302605. doi: 10.1371/journal.pone.0302605. eCollection 2025.
3
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
4
Pyrimidine Azepine Targets the Complex and Displays Multistage Antimalarial Activity.嘧啶氮杂卓作用于该复合物并展现出多阶段抗疟活性。
JACS Au. 2024 Oct 7;4(10):3942-3952. doi: 10.1021/jacsau.4c00674. eCollection 2024 Oct 28.
5
A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models.在小鼠模型中,具有复制能力的痘苗病毒和基于腺相关病毒1型的疟疾疫苗与RTS,S/AS01的头对头比较研究。
Vaccines (Basel). 2024 Oct 10;12(10):1155. doi: 10.3390/vaccines12101155.
6
A human-serum-free medium can induce more infectious P. falciparum gametocytes than a conventional human-serum-containing medium.无血清培养基比传统含血清培养基更能诱导疟原虫感染性配子体的产生。
Sci Rep. 2024 Sep 27;14(1):22052. doi: 10.1038/s41598-024-73843-5.
7
Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria.多阶段保护型抗 CelTOS 单克隆抗体,对疟疾具有跨物种的无菌保护作用。
Nat Commun. 2024 Aug 29;15(1):7487. doi: 10.1038/s41467-024-51701-2.
8
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development.用于疟疾根除的传播阻断策略:小分子药物开发的最新进展
Pharmaceuticals (Basel). 2024 Jul 19;17(7):962. doi: 10.3390/ph17070962.
9
Malaria vaccines: a new era of prevention and control.疟疾疫苗:预防和控制的新时代。
Nat Rev Microbiol. 2024 Dec;22(12):756-772. doi: 10.1038/s41579-024-01065-7. Epub 2024 Jul 18.
10
A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity.一种自组装的Pfs230D1-铁蛋白纳米颗粒疫苗具有强大且持久的减少疟疾传播活性。
Vaccines (Basel). 2024 May 16;12(5):546. doi: 10.3390/vaccines12050546.

本文引用的文献

1
Statistical Methods for Standard Membrane-Feeding Assays to Measure Transmission Blocking or Reducing Activity in Malaria.用于测量疟疾传播阻断或减少活性的标准膜饲法的统计方法
J Am Stat Assoc. 2018;113(522):534-545. doi: 10.1080/01621459.2017.1356313. Epub 2018 Jun 12.
2
Transmission blocking malaria vaccines: Assays and candidates in clinical development.传播阻断型疟疾疫苗:临床开发中的检测方法与候选疫苗
Vaccine. 2015 Dec 22;33(52):7476-82. doi: 10.1016/j.vaccine.2015.08.073. Epub 2015 Sep 26.
3
A novel multiple-stage antimalarial agent that inhibits protein synthesis.一种新型的多阶段抗疟药物,可抑制蛋白质合成。
Nature. 2015 Jun 18;522(7556):315-20. doi: 10.1038/nature14451.
4
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.针对恶性疟原虫的传播阻断候选疫苗的比较评估。
Sci Rep. 2015 Jun 11;5:11193. doi: 10.1038/srep11193.
5
Development of malaria transmission-blocking vaccines: from concept to product.疟疾传播阻断疫苗的研发:从概念到产品
Adv Parasitol. 2015 Jun;89:109-52. doi: 10.1016/bs.apar.2015.04.001. Epub 2015 May 8.
6
Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.用于评估疫苗和药物对恶性疟原虫传播阻断活性的稳健、可重复、工业化标准膜饲法。
Malar J. 2015 Apr 9;14:150. doi: 10.1186/s12936-015-0665-8.
7
Toward the development of effective transmission-blocking vaccines for malaria.迈向开发有效的疟疾传播阻断疫苗。
Expert Rev Vaccines. 2015 May;14(5):653-80. doi: 10.1586/14760584.2015.993383. Epub 2015 Jan 19.
8
Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions.疟原虫配子体密度与蚊虫感染成功率关系的实验研究;对评估减少疟疾传播干预措施的影响。
Exp Parasitol. 2015 Feb;149:74-83. doi: 10.1016/j.exppara.2014.12.010. Epub 2014 Dec 23.
9
A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.一种用于鉴定具有生物学相关性的疟疾传播阻断药物的雌雄配子体功能活力测定法。
Antimicrob Agents Chemother. 2014 Dec;58(12):7292-302. doi: 10.1128/AAC.03666-14. Epub 2014 Sep 29.
10
Gametocytocidal screen identifies novel chemical classes with Plasmodium falciparum transmission blocking activity.配子体杀灭筛选鉴定出具有恶性疟原虫传播阻断活性的新型化学类别。
PLoS One. 2014 Aug 26;9(8):e105817. doi: 10.1371/journal.pone.0105817. eCollection 2014.

在恶性疟原虫标准膜饲实验中,传播阻断活性由传播减少活性和对照卵囊数量共同决定。

Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.

作者信息

Miura Kazutoyo, Swihart Bruce J, Deng Bingbing, Zhou Luwen, Pham Thao P, Diouf Ababacar, Burton Timothy, Fay Michael P, Long Carole A

机构信息

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbrook Parkway, Rockville, MD 20852, USA.

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20852, USA.

出版信息

Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.

DOI:10.1016/j.vaccine.2016.06.066
PMID:27372156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4958521/
Abstract

Malaria transmission-blocking vaccines (TBVs) are potentially helpful tools for malaria eradication. The standard membrane-feeding assay (SMFA) is considered one of the "gold standard" assays for TBV development. However, lack of consensus in reporting results from SMFA has made it very challenging to compare results from different studies. Two main readouts, % inhibition in mean oocyst count per mosquito (TRA) and % inhibition in prevalence of infected mosquitoes (TBA), have been used widely. In this study, we statistically modeled the oocyst data in SMFA using data from 105 independent feeding experiments including 9804 mosquitoes. The model was validated using an independent data set that included 10,790 mosquitoes from 110 feeding studies. The model delineates a relationship between TRA, the mean oocyst count in the control mosquitoes (mo-contl), and TBA. While TRA was independent from mo-contl, TBA values changed depending on mo-contl. Regardless of monoclonal or polyclonal antibodies tested, there were strong concordances between observed TBA and predicted TBA based on the model using mo-contl and observed TRA. Simulations showed that SMFA with lower true control means had increased uncertainty in TRA estimates. The strong linkage between TBA, TRA and mo-contl inspired creation of a standardized TBA, a model-based TBA standardized to a target control mean, which allows comparison across multiple feeds regardless of mo-contl. This is the first study showing that the observed TBA can be reasonably predicted by mo-contl and the TRA of the test antibody using independent experimental data. This study indicates that TRA should be used to compare results from multiple feeds with different levels of mo-contl. If a measure of TBA is desired, it is better to report standardized TBA rather than observed TBA. These recommendations support rational comparisons of results from different studies, thus benefiting future TBV development.

摘要

疟疾传播阻断疫苗(TBVs)是根除疟疾的潜在有用工具。标准膜饲法(SMFA)被认为是TBV研发的“金标准”检测方法之一。然而,在报告SMFA结果方面缺乏共识,使得比较不同研究的结果极具挑战性。两个主要的读数,即每只蚊子平均卵囊计数的抑制率(TRA)和受感染蚊子患病率的抑制率(TBA),已被广泛使用。在本研究中,我们使用来自105项独立饲育实验(包括9804只蚊子)的数据,对SMFA中的卵囊数据进行了统计建模。该模型使用一个独立数据集进行了验证,该数据集包括来自110项饲育研究的10790只蚊子。该模型描绘了TRA、对照蚊子的平均卵囊计数(mo-contl)和TBA之间的关系。虽然TRA与mo-contl无关,但TBA值会根据mo-contl而变化。无论测试的是单克隆抗体还是多克隆抗体,基于使用mo-contl和观察到的TRA的模型,观察到的TBA与预测的TBA之间都有很强的一致性。模拟表明,真实对照均值较低的SMFA在TRA估计中具有更大的不确定性。TBA、TRA和mo-contl之间的紧密联系促使创建了一种标准化的TBA,即基于模型的TBA,标准化到目标对照均值,这使得无论mo-contl如何,都可以在多个饲育实验之间进行比较。这是第一项表明可以使用独立实验数据通过mo-contl和测试抗体的TRA合理预测观察到的TBA的研究。本研究表明,应使用TRA来比较不同mo-contl水平的多个饲育实验的结果。如果需要测量TBA,最好报告标准化的TBA而不是观察到的TBA。这些建议支持对不同研究结果进行合理比较,从而有利于未来TBV的研发。